Saturday, July 21, 2012
Singapore - US Medical Device Maker Greatbatch To Establish R&D Center in Singapore
Greatbatch, Inc. today announced that the company will establish an Active Implantable Medical Device (AIMD) Research and Development Center in Singapore.
Greatbatch, Inc. today announced that the company will establish an Active Implantable Medical Device (AIMD) Research and Development Center in Singapore – the first of its kind in the country.
The establishment of this center is a continuation of Greatbatch’s medical device strategy and the first step of its Asia Pacific strategy to engage in emerging healthcare markets.
“Many factors contributed to our decision to establish the first multinational R&D center for active implantable medical devices in Singapore, including the nation’s commitment to developing its biomedical sciences cluster, as evidenced by its strong investment in research organizations,” said Thomas J. Hook, President and CEO of Greatbatch.
The Greatbatch Singapore AIMD R&D Center will immediately focus on the design and development of active implantable medical devices to serve the Cardiovascular and Neuromodulation markets. Both are multibillion dollar markets with considerable long-term growth potential.
To serve the Cardiovascular market, the company has identified needs in Interventional Procedures, Atrial Fibrillation ablation, MRI Conditional Systems, as well as targeting health conditions related to Cardiovascular Disease with therapies for Obesity and Obstructive Sleep Apnea. To serve the Neuromodulation market, the company is currently developing a Spinal Cord Stimulator called Algostim, which will treat chronic pain in the trunk and limbs.
“The devices that the Greatbatch Singapore AIMD R&D Center will design and develop are to be tailored to the unique requirements that exist in emerging markets without sacrificing physician and patient benefits,” said Daniel Kaiser, PhD., Chief Technology Officer of Greatbatch.
“In order to develop such complex systems we’ll focus on world class talent with the capabilities to bring these solutions through the development and regulatory stages to serve Asia Pacific and broader worldwide healthcare markets.”
The new center will be headed by Kulbir Sandhu, who was formerly Senior Director of R&D at St. Jude Medical Center in the United States. Sandhu has over 15 years of medical device experience in the areas of new product development, program management, and manufacturing transfer.
Greatbatch’s latest venture in Singapore is a significant development for the country’s biomedical sector – it is the first R&D center for active implantable medical devices in Singapore and in Asia.
Source: Greatbatch, Inc.